Product Quality and Safety Assessments

Veterinary Medicinal Product Safety and Risk Management

The Animal Health Global Pharmacovigilance (GPV) team manages a system for the collection, review and reporting of adverse events, and for the ongoing assessment of product safety. GPV leads all safety monitoring and signal management activities for the Animal Health veterinary medicinal products portfolio, from the time of product approval through the end of its lifecycle.

Research and Development

We responsibly test our investigative Animal Health pharmaceuticals and vaccines vigorously for safety, quality and efficacy before submitting them for approval, which can be obtained only after thorough review by independent regulatory authorities. In addition, when used in food-producing animals, our submissions to regulatory agencies include rigorous human food safety testing as well as user safety and environmental safety assessments.

This testing and refining of a product can take years to complete. When the required testing is complete and found to be satisfactory by the appropriate government regulatory agencies, the product is approved to be marketed. Once a product is on the market, we follow all applicable pharmacovigilance rules and report our findings to regulatory authorities.

Regulatory Affairs

A consistent, science-based regulatory environment is one of the conditions necessary for innovation and for providing our customers with high-quality products.

We support global harmonization of the regulatory process for veterinary medicines through our global trade association, HealthforAnimals, which is recognized as an observer organization. This allows HealthforAnimals to offer input and provide perspectives in meetings with international standards- setting bodies, including the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).

For more information, please visit the Ethical Treatment of Animals page